Search PubMed⌕ Search

Biomedical subjects

J Shaw

Publications and source records attributed to J Shaw.

375 records · Page 21Linked to original sources
PubMedDate not supplied

Psychodopygus complexus, a new vector of Leishmania braziliensis to humans in Pará State, Brazil.

This paper reports the finding of 4 specimens of Psychodopygus complexus, captured in the Paragominas region of Pará State, Brazil, naturally infected with trypanosomatids that were positively identified as Leishmania (Viannia) braziliensis. Attention is drawn to the importance of this species as a vector since it is highly anthropophilic and has a very extensive geographical distribution in the lower Amazon region of Pará State south of the Amazon river, including the island of Marajó.

Animals↗
PubMedDate not supplied

[The laboratory diagnosis and epidemiology of cutaneous leishmaniasis in Paraná State, southern Brazil].

Between 1986 and 1997 a total of 1418 patients were examined at the Clinical Analysis Teaching and Research Laboratory of Maringá State University (LEPAC/UEM) for cutaneous leishmaniasis by direct examination of stained smears made from the lesions, the Montenegro skin test and the indirect immunofluorescent antibody test. Nine hundred and fifty five patients (67.3%) were positive for at least one of the three tests and of these 804 (84.2%) were considered to have contracted the disease in Paraná State; 665 (69.6%) were between 15 and 49 years old; 658 (68.9%) were males; 523 (54.8%) sought medical advice during the first three months of their infections and 74 (7.7%) had mucosal lesions. Of the 83 counties of Paraná State, where the patients had most probably acquired their infections, 44.7% were from the counties of São Jorge do Ivaí (10.2%), Doutor Camargo (9.8%), Terra Boa (7.3%), Maringá (7.3%), Jussara (6.0%) and Cianorte (4.5%). Seventy seven strains of Leishmania (Viannia) braziliensis were isolated and 63.6% of these strains belong to serodema 1.

Adolescent↗
PubMedDate not supplied

Second Australian National Blood Pressure Study (ANBP2). Australian Comparative Outcome Trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of Australia.

The Second Australian National Blood Pressure Study (ANBP2) is a comparative outcome trial being conducted in general practices throughout Australia of ACE inhibitor- and diuretic-based treatment in 6000 hypertensive patients aged 65-84 years. The study is using a prospective randomised open-label design with blinding of endpoint assessments. The primary objective is to determine whether there is any difference in total cardiovascular events (fatal and non-fatal) over a five year treatment period between the two treatment regimens. Eligible hypertensive patients (average sitting blood pressure at the 2nd and 3rd screening visits > 160 mm Hg systolic and/or > 90 mm Hg diastolic) may be either untreated or previously treated and should have no history of recent cardiovascular morbidity or serious intercurrent illness. Patients are randomised to one of the treatment arms with randomisation stratified for practice and for age. Following randomisation each patient's blood pressure is managed by his/her general practitioner according to guidelines relevant to each treatment arm. Over 700 patients have now been randomised with recruitment intended to be complete by the end of 1997.

Aged↗
PubMedDate not supplied

Check them out.

Explore the source record for details and available documents.

Attitude to Health↗